Popular articles

Is iodine 131 used to treat thyroid cancer?

Is iodine 131 used to treat thyroid cancer?

Because of this, radioactive iodine (RAI, also called I-131) can be used to treat thyroid cancer. The RAI collects mainly in thyroid cells, where the radiation can destroy the thyroid gland and any other thyroid cells (including cancer cells) that take up iodine, with little effect on the rest of your body.

How does iodine 131 diagnose thyroid cancer?

Thyroid is the critical organ for iodine. Iodine is taken up by the thyroid follicular cells. Radioactive isotope iodine-131 simultaneously emits two types of radiation: radiation beta minus (β-) used for the treatment and gamma (γ) used for diagnosis.

What type of cancer is associated with iodine 131 exposure?

People exposed to I-131, especially during childhood, may have an increased risk of thyroid disease, including thyroid cancer. Thyroid cancer is uncommon and is usually curable. Typically, it is a slow-growing cancer that is highly treatable.

Why is iodine 131 used to treat thyroid cancer?

It uses a radioactive form of iodine called iodine 131 (I-131). It is a useful treatment in thyroid cancer because the thyroid gland absorbs and stores most of the iodine in your body. The thyroid gland gets iodine from certain foods and uses this to make essential thyroid hormones.

What is the half life of iodine 131?

The half life of Iodine-131 is about 692,988.00 seconds

What is iodine 131 therapy?

Iodine-131 therapy (also known as RAI) is a targeted form of radiation therapy. It’s been used for many years to treat: When it’s used to treat thyroid cancer, iodine-131 therapy gets rid of any cancerous tissue left behind after your thyroid gland has been removed (thyroidectomy).

Who treats thyroid cancer?

An endocrinologist is the physician who deals primarily with the diagnosis, treatment and follow-up of most patients with thyroid cancer. However, if/when standard therapy fails to control the progression of thyroid cancer and chemotherapy is being considered, then consultation with an oncologist is appropriate.